Atomistry » Chlorine » PDB 4j93-4jk9 » 4jec
Atomistry »
  Chlorine »
    PDB 4j93-4jk9 »
      4jec »

Chlorine in PDB 4jec: Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir

Enzymatic activity of Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir

All present enzymatic activity of Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir:
3.4.23.16;

Protein crystallography data

The structure of Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir, PDB code: 4jec was solved by A.Y.Kovalevsky, I.T.Weber, P.Langan, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) N/A / 2.01
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 59.186, 87.431, 46.405, 90.00, 90.00, 90.00
R / Rfree (%) 24.4 / 26.1

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir (pdb code 4jec). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir, PDB code: 4jec:

Chlorine binding site 1 out of 1 in 4jec

Go back to Chlorine Binding Sites List in 4jec
Chlorine binding site 1 out of 1 in the Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Joint Neutron and X-Ray Structure of Per-Deuterated Hiv-1 Protease in Complex with Clinical Inhibitor Amprenavir within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl601

b:44.9
occ:1.00
 HE1 A:TRP6 2.3 27.0 0.3
DE1 A:TRP6 2.3 27.0 0.7
D2 B:DOD507 2.6 27.3 1.0
DZ2 A:TRP6 3.1 26.7 0.6
HZ2 A:TRP6 3.1 26.7 0.4
NE1 A:TRP6 3.2 28.7 1.0
O B:DOD507 3.4 27.6 1.0
DG22 A:THR4 3.6 26.4 0.8
HG22 A:THR4 3.6 26.4 0.2
CZ2 A:TRP6 3.9 26.3 1.0
CE2 A:TRP6 3.9 25.2 1.0
D1 B:DOD507 3.9 27.6 1.0
D1 A:DOD702 4.0 31.0 1.0
HB A:THR4 4.2 25.3 0.5
DB A:THR4 4.2 25.3 0.5
CD1 A:TRP6 4.3 24.5 1.0
CG2 A:THR4 4.5 26.2 1.0
DG21 A:THR4 4.6 26.4 1.0
HD1 A:TRP6 4.6 25.1 1.0
DA3 B:GLY194 4.8 26.2 1.0
O A:DOD702 4.9 30.0 1.0
CB A:THR4 4.9 25.2 1.0

Reference:

I.T.Weber, M.J.Waltman, M.Mustyakimov, M.P.Blakeley, D.A.Keen, A.K.Ghosh, P.Langan, A.Y.Kovalevsky. Joint X-Ray/Neutron Crystallographic Study of Hiv-1 Protease with Clinical Inhibitor Amprenavir: Insights For Drug Design. J.Med.Chem. V. 56 5631 2013.
ISSN: ISSN 0022-2623
PubMed: 23772563
DOI: 10.1021/JM400684F
Page generated: Sun Jul 21 17:24:19 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy